• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of endothelin in the physiological closure of Ductus Artenosus

Research Project

Project/Area Number 14570076
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General pharmacology
Research InstitutionAsahikawa Medical College

Principal Investigator

TANIGUCHI Takanobu  Asahikawa Medical College, Biochemistry 1, Professor, 医学部, 教授 (60217130)

Co-Investigator(Kenkyū-buntansha) MURAMATSU Ikunobu  Fukui Medical University, Pharmacology, Professor, 医学部, 教授 (10111965)
Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥3,600,000 (Direct Cost: ¥3,600,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2002: ¥2,300,000 (Direct Cost: ¥2,300,000)
KeywordsDuctuc Artenosus / endothelin / indomethacin
Research Abstract

1)Ductus arteriosus(DA) undergoes rapid closure after birth as pulmonary circulation is established The mechanism of the closure is controversial regarding an involvement of endothelin(ET).
2)The effect of ATZ1993(ATZ), a non-peptide antagonist for the ET_A and ET_B receptors, on postnatal closure and O_2-induced contraction of the rat DA was investigated both in vivo and in vitro. Rat pups were delivered by Caesarean section and were given ATZ intraperitoneally. The minimum external DA diameter and the extent of DA constriction in vivo were evaluated at 25 h after birth. ATZ caused a dose-dependent inhibition of DA closure in vivo. When rat pups were given ATZ at 2.5 h after birth, re-opening of the DA was observed.
3)In vitro, ATZ also caused a marked inhibition of O_2-induced and ET1-induced DA contractions as did BQ123, a ET_A-specific antagonist. In contrast, sarafotoxin S6c, an ET_B-specific agonist, did not cause DA contraction and BQ 788, an ET_B-specific antagonist, did not affect O_2-induced DA contraction.
4)ET and its cognate receptor ET_A can play a physiological role in the postnatal closure of the rat DA in vivo.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Ishida A, Shigeri Y, Taniguchi T, Kameshita I.: "Protein phosphatases that regulate multifunctional Ca2+/calmodulin-dependent protein kinases : from biochemistry to pharmacology."Pharmacol Ther. 100(3). 291-305 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Taniguchi T, Muramatsu I.: "Pharmacological knockout of endothelin ET(A) receptors"Life Sci. 74(2-3). 405-409 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yamada T, Taniguchi T, Shiokoshi T, Narumiya S, Ushikubi F.: "Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase."Circulation. 108(19). 2381-2386 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hiraoka Y, Taniguchi T, Tanaka T, Kanamaru H, Muramatsu I.: "Pharmacological characterization of unique prazosin-binding sites in human kidney"Naunyn Schmiedebergs Arch Pharmacol. 368(1). 49-56 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takahashi M, Taniguchi_T, Tanaka T, Kanamaru H, Muramatsu I.: "Pharmacological characterization of TA-0201, an endothelia receptor antagonist, with recombinant and human prostate endothelin receptors"Eur J Pharmacol. 467(1-3). 185-189 (2003)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ishida A, Shigeri Y, Taniguchi T, Kameshita I.: "Protein phosphatases that regulate multifunctional Ca2+/calmodulin-dependent protein kinases : from biochemistry to pharmacology."Pharmacol Ther. 100(3). 291-305 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Taniguchi T, Muramatsu I.: "Pharmacological knockout of endothelin ET(A) receptors"Life Sci. 74(2-3). 405-409 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Yamada T, Taniguchi T, Shiokoshi T, Narumiya S, Ushikubi F.: "Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase."Circulation. 108(19). 2381-2386 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Hiraoka Y, Taniguchi T, Tanaka T, Kanamaru H, Muramatsu I.: "Pharmacological characterization of unique prazosin-binding sites in human kidney"Naunyn Schmiedebergs Arch Pharmacol. 368(1). 49-56 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Takahashi M, Taniguchi T, Tanaka T, Kanamaru H, Murarnatsu: "Pharmacological characterization of TA-O201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors"Eur J Pharmacol. 467(1-3). 185-189 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Ishida A, Shigeri Y, Taniguchi T, Kameshita I.: "Protein phosphatases that regulate multifunctional Ca2+/calmodulin-dependent protein kinases : from biochemistry to pharmacology"Pharmacol Ther. 100(3). 291-305 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Taniguchi T, Muramatsu I.: "Pharmacological knockout of endothelin ET(A) receptors"Life Sci. 74(2-3). 405-409 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Yamada T, Taniguchi T, Shiokoshi T, Narumiya S, Ushikubi F.: "Thromboxane A2 regulates vascular tone via its inhibitory effect on the expression of inducible nitric oxide synthase"Circulation. 108(19). 2381-2386 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Hiraoka Y, Taniguchi T, Tanaka T, Kanamaru H, Muramatsu I.: "Pharmacological characterization of unique prazosin-binding sites in human kidney"Naunyn Schmiedebergs Arch Pharmacol. 368(1). 49-56 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] Takahashi M, Taniguchi T, Tanaka T, Kanamaru H, Muramatsu I.: "Pharmacological characterization of TA-0201, an endothelin receptor antagonist, with recombinant and human prostate endothelin receptors"Eur J Pharmacol. 467(1-3). 185-189 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] T.Taniguchi, H.Azuma, Y.Okada, H.Naiki, M.D.Hollenberg, I.Muramatsu: "Endothelin-1-endothelin receptor type A mediates closure of rat ductus arteriosus at birth"J Physiol. 537(2). 579-585 (2001)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi